Новые рассуждения на тему мигрени как фактора риска сердечно-сосудистых нарушений и роль гиперинтенсивности белого вещества: все ли золото, что блестит?

  • C. Tana Department of Medicine, “G. D’Annunzio” University of Chieti, and Center of Excellence on Aging, “G. D’Annunzio” University Foundation, Chieti, Italy; Center of Excellence on Headache, “S.S. Annunziata” Hospital, Chieti, Italy
  • E. Tafuri Department of Medicine, “G. D’Annunzio” University of Chieti, and Center of Excellence on Aging, “G. D’Annunzio” University Foundation, Chieti, Italy; Center of Excellence on Headache, “S.S. Annunziata” Hospital, Chieti, Italy
  • M. Tana Department of Medicine, “G. D’Annunzio” University of Chieti, and Center of Excellence on Aging, “G. D’Annunzio” University Foundation, Chieti, Italy
  • P. Martelletti Department of Clinical and Molecular Medicine, Regional Referral Headache Centre, “Sant’Andrea” Hospital, “Sapienza” University, Rome, Italy
  • A. Negro Department of Clinical and Molecular Medicine, Regional Referral Headache Centre, “Sant’Andrea” Hospital, “Sapienza” University, Rome, Italy
  • G. Affaitati Department of Medicine, “G. D’Annunzio” University of Chieti, and Center of Excellence on Aging, “G. D’Annunzio” University Foundation, Chieti, Italy
  • A. Fabrizio Department of Medicine, “G. D’Annunzio” University of Chieti, and Center of Excellence on Aging, “G. D’Annunzio” University Foundation, Chieti, Italy; Center of Excellence on Headache, “S.S. Annunziata” Hospital, Chieti, Italy
  • A. Costantini Institute of Surgical Pathology, “G. D’Annunzio” University, Chieti, Italy
  • A. Mezzetti Department of Medicine, “G. D’Annunzio” University of Chieti, and Center of Excellence on Aging, “G. D’Annunzio” University Foundation, Chieti, Italy
  • M.A. Giamberardino Department of Medicine, “G. D’Annunzio” University of Chieti, and Center of Excellence on Aging, “G. D’Annunzio” University Foundation, Chieti, Italy; Center of Excellence on Headache, “S.S. Annunziata” Hospital, Chieti, Italy

Литература

1. Perk J., De Backer G., Gohlke H., Graham I., Reiner Z., Verschuren M., Albus C., Benlian P., Boysen G., Cifkova R., Deaton C., Ebrahim S., Fisher M., Germano G., Hobbs R., Hoes A., Karadeniz S., Mezzani A., Prescott E., Ryden L., Scherer M., Syvanne M., Scholte op Reimer W.J., Vrints C., Wood D., Zamorano J.L., Zannad F. European guidelines on cardiovascular disease prevention in clinical practice // Eur Heart J, 2012, 33, 1635–1701.
2. Redberg R.F., Benjamin E.J., Bittner V., Braun L.T., Goff D.C. Jr, Havas S., Labarthe D.R., Limacher M.C., Lloyd-Jones D.M., Mora S., Pearson T.A., Radford M.J., Smetana G.W., Spertus J.A., Swegler E.W. American Academy of Family Physicians; American Association of Cardiovascular and Pulmonary Rehabilitation; Preventive Cardiovascular Nurses Association ACCF/ AHA 2009 performance measures for primary prevention of cardiovascular disease in adults // J Am Coll Cardiol, 2009, 54 (14),1364–1405.
3. Yusuf S., Hawken S., Ounpuu S., Dans T., Avezum A., Lanas F., McQueen M., Budaj A., Pais P., Varigos J., Lisheng L. INTERHEART Study Investigators. Effect of potentially modifiable risk factors
Полный список литературы находится в редакции.
Опубликована
янв 27, 2017
Как цитировать
TANA, C. et al. Новые рассуждения на тему мигрени как фактора риска сердечно-сосудистых нарушений и роль гиперинтенсивности белого вещества: все ли золото, что блестит?. Украинский журнал боли, [S.l.], v. 6, n. 2, p. 7-12, янв. 2017. ISSN 2303-9736. Доступно на: <http://journal.pain.ua/ujp/article/view/44>. Дата получения: 21 окт. 2019